These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1512250)

  • 21. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.
    Ramakrishnan V; Sinicropi DV; Dere R; Darbonne WC; Bechtol KB; Baker JB
    J Biol Chem; 1990 Feb; 265(5):2755-62. PubMed ID: 2105933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
    Kunitada S; FitzGerald GA; Fitzgerald DJ
    Blood; 1992 Mar; 79(6):1420-7. PubMed ID: 1547340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitronectin governs the interaction between plasminogen activator inhibitor 1 and tissue-type plasminogen activator.
    Keijer J; Ehrlich HJ; Linders M; Preissner KT; Pannekoek H
    J Biol Chem; 1991 Jun; 266(16):10700-7. PubMed ID: 1709939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.
    Wilhelm OG; Jaskunas SR; Vlahos CJ; Bang NU
    J Biol Chem; 1990 Aug; 265(24):14606-11. PubMed ID: 2117612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.
    Sakata Y; Loskutoff DJ; Gladson CL; Hekman CM; Griffin JH
    Blood; 1986 Dec; 68(6):1218-23. PubMed ID: 3096399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.
    Russell ME; Quertermous T; Declerck PJ; Collen D; Haber E; Homcy CJ
    J Biol Chem; 1990 Feb; 265(5):2569-75. PubMed ID: 2105930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
    Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
    Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Kaneko M; Sakata Y; Matsuda M; Mimuro J
    J Biochem; 1992 Feb; 111(2):244-8. PubMed ID: 1314812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
    Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
    Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1. The effects of fibrinogen, heparin, vitronectin, and lipoprotein(a).
    Edelberg JM; Reilly CF; Pizzo SV
    J Biol Chem; 1991 Apr; 266(12):7488-93. PubMed ID: 1708387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between tissue-type plasminogen activator and extracellular matrix-associated plasminogen activator inhibitor type 1 in the human hepatoma cell line HepG2.
    Owensby DA; Morton PA; Schwartz AL
    J Biol Chem; 1989 Oct; 264(30):18180-7. PubMed ID: 2553701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator inhibitor: a regulator of ancrod-induced fibrin deposition in rabbits.
    Krishnamurti C; Barr CF; Hassett MA; Young GD; Alving BM
    Blood; 1987 Mar; 69(3):798-803. PubMed ID: 3101764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y; Okada M; Noro A; Matsuda M
    J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
    Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
    Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The resistance of fibrin-stimulated tissue plasminogen activator to inactivation by a class PAI-2 inhibitor (minactivin).
    Leung KC; Byatt JA; Stephens RW
    Thromb Res; 1987 Jun; 46(6):755-66. PubMed ID: 2957818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level.
    Wun TC; Capuano A
    Blood; 1987 May; 69(5):1354-62. PubMed ID: 3105619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L; Lijnen HR; Collen D; Holmes WE
    J Biol Chem; 1987 Aug; 262(22):10855-62. PubMed ID: 2956260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator inhibitor 1.
    Thelwell C; Longstaff C
    J Thromb Haemost; 2007 Apr; 5(4):804-11. PubMed ID: 17408411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.